Satellos to Participate in November Investor Conferences
TORONTO — Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) ("Satellos" or the "Company"), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, today announced that its leadership team will present
(Financial Post, 2025-10-30T11:08:05Z)